You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

decitabine

Showing 1 - 25 of 220
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

Recruiting
  • AML
  • MDS
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hospital
Nov 30, 2023

Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

Not yet recruiting
  • Poor Graft Function
  • Decitabine
  • +3 more
  • (no location specified)
Jun 8, 2023

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • Decitabine
  • +3 more
  • Maywood, Illinois
    Loyola University Medical Center
Aug 1, 2023

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Mar 1, 2023

Healthy Trial in San Antonio (Decitabine, Tetrahydrouridine)

Recruiting
  • Healthy
  • San Antonio, Texas
    Worldwide Clinical Trails Early Phase Services
Apr 14, 2023

Recurrent Acute Myeloid Leukemia Trial in Nashville (Venetoclax, Decitabine, Cedazuridine)

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Mar 22, 2023

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Decitabine
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • decitabine
  • +4 more
  • (no location specified)
Dec 29, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Decitabine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Refractory Aplastic Anemia Trial in Tianjin (Decitabine)

Terminated
  • Refractory Aplastic Anemia
  • Decitabine
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Aug 25, 2022

MDS, AML Trial in Bronx (Venetoclax, Decitabine)

Recruiting
  • MDS
  • AML
  • Bronx, New York
    Montefiore Medical Center
Jul 22, 2022

Recurrent Leukemia, Refractory Leukemia Trial in Houston (Decitabine, Tegavivint)

Recruiting
  • Recurrent Leukemia
  • Refractory Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine, Navitoclax, Venetoclax)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Decitabine
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)

Recruiting
  • Myelodysplastic Syndromes
  • MDS/MPN Crossover Syndromes
  • Cleveland, Ohio
    Cleveland Medical Center, University Hospitals Seidman Cancer Ce
Aug 10, 2022

Blasts More Than 20 Percent of Bone Marrow Nucleated Cells, Blasts More Than 20 Percent of Peripheral Blood White Cells,

Completed
Has Results
  • Blasts More Than 20 Percent of Bone Marrow Nucleated Cells
  • +4 more
  • Decitabine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Acute Myelogenous Leukemia Trial in Rochester (Decitabine)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Decitabine
  • Rochester, New York
    University of Rochester
Jul 1, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Decitabine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Decitabine
  • +3 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 22, 2023

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • STAT Inhibitor OPB-111077
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Dec 20, 2022

Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Nov 2, 2022

Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

Recruiting
  • Myeloid Malignancy
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 23, 2022